TP53 and breast carcinoma: In breast cancer, hsa-miR-145 has been confirmed to be involved in pro-apoptotic activities in collaboration with TP53 and represses expression of ESR-alpha by directly binding to its 3′UTR (Spizzo et al., 2010).